SC
OGN icon

Swan Capital’s Organon & Co OGN Stock Holding History

Swan Capital’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$192 Hold
32
– – ﹤0.01% 521
2025
Q4 		$229 Hold
32
– – ﹤0.01% 479
2025
Q3 		$342 Hold
32
– – ﹤0.01% 447
2025
Q2 		$310 Hold
32
– – ﹤0.01% 434
2025
Q1 		$476 Hold
32
– – ﹤0.01% 325
2024
Q4 		$477 Hold
32
– – ﹤0.01% 325
2024
Q3 		$612 Hold
32
– – ﹤0.01% 290
2024
Q2 		$662 Buy
+32
New +$636 ﹤0.01% 243

Other funds holding OGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

Swan Capital's OGN Position: Q1 2026 in Review

Swan Capital held its Organon & Co (OGN) position steady in Q1 2026 at 32 shares worth $192. The position accounts for ﹤0.01% of the portfolio, ranked #521.

Swan Capital first reported a position in OGN in Q2 2024 and has held it in 8 quarters since. The position peaked at $662 in Q2 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Swan Capital held 32 shares of Organon & Co worth $192 as of Q1 2026.
  • Swan Capital left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Swan Capital's portfolio in Q1 2026, its #521 holding.
  • Swan Capital first reported a position in Organon & Co in Q2 2024 and has held it in 8 quarters since.
  • Swan Capital's Organon & Co position peaked at $662 in Q2 2024.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Swan Capital's 13F filing for Q1 2026, filed 14 May 2026.